Yan Z, Song W J, Surmeier J
Department of Anatomy and Neurobiology, College of Medicine, University of Tennessee, Memphis 38163, USA.
J Neurophysiol. 1997 Feb;77(2):1003-15. doi: 10.1152/jn.1997.77.2.1003.
Dopamine has long been known to regulate the activity of striatal cholinergic interneurons and the release of acetylcholine. Yet, the cellular mechanisms by which this regulation occurs have not been elucidated. One way in which dopamine might act is by modulating voltage-dependent Ca2+ channels. To test this hypothesis, the impact of dopaminergic agonists on Ca2+ channels in neostriatal cholinergic interneurons was studied by combined whole cell voltage-clamp recording and single-cell reverse transcription-polymerase chain reactions. Cholinergic interneurons were identified by the presence of choline acetyltransferase mRNA. Nearly, all interneurons tested (90%, n = 17) coexpressed D2 (short and long isoforms) and D1b (D5) dopamine receptor mRNAs. D1a receptor mRNA was found in only a small subset (20%) of the sample and D3 and D4 receptor mRNAs were undetectable. D2 receptor agonists rapidly and reversibly reduced N-type Ca2+ currents. D1b/D1a receptor activation had little or no effect on Ca2+ currents. The D2 receptor antagonist sulpiride blocked the effect of D2 agonists. Dialysis with guanosine-5'-O-(2-thiodiphosphate) or brief exposure to the G protein (Gi/o) alkylating agent N-ethylmaleimide also blocked the D2 modulation. The reduction in N-type currents was neither accompanied by kinetic slowing nor significantly reversed by depolarizing prepulses. The D2 receptor effects were mediated by a membrane-delimited pathway, because the modulation was not seen in cell-attached patches when agonist was applied to the bath and was not disrupted by perturbations in cytosolic signaling pathways known to be linked to D2 receptors. Activation of M2 muscarinic receptors occluded the D2 modulation, suggesting a shared signaling element. However, activation of protein kinase C attenuated the M2 modulation without significantly affecting the D2 modulation. Taken together, our results suggest that activation of D2 dopamine receptors in cholinergic interneurons reduces N-type Ca2+ currents via a membrane-delimited, Gi/o class G protein pathway that is not regulated by protein kinase C. This signaling pathway may underlie the ability of D2 receptors to reduce striatal acetylcholine release.
长期以来,人们一直认为多巴胺可调节纹状体胆碱能中间神经元的活性及乙酰胆碱的释放。然而,这种调节发生的细胞机制尚未阐明。多巴胺可能起作用的一种方式是通过调节电压依赖性Ca2+通道。为验证这一假说,采用全细胞膜片钳记录与单细胞逆转录-聚合酶链反应相结合的方法,研究了多巴胺能激动剂对新纹状体胆碱能中间神经元Ca2+通道的影响。通过胆碱乙酰转移酶mRNA的存在来鉴定胆碱能中间神经元。几乎所有测试的中间神经元(90%,n = 17)共表达D2(短和长亚型)和D1b(D5)多巴胺受体mRNA。仅在一小部分样本(20%)中发现D1a受体mRNA,未检测到D3和D4受体mRNA。D2受体激动剂可迅速且可逆地降低N型Ca2+电流。D1b/D1a受体激活对Ca2+电流几乎没有影响。D2受体拮抗剂舒必利可阻断D2激动剂的作用。用鸟苷-5'-O-(2-硫代二磷酸)透析或短暂暴露于G蛋白(Gi/o)烷基化剂N-乙基马来酰亚胺也可阻断D2调节。N型电流的降低既不伴有动力学减慢,也不会因去极化预脉冲而显著逆转。D2受体效应由膜限定途径介导,因为当激动剂应用于浴液时,在细胞贴附膜片中未观察到调节作用,且已知与D2受体相关的胞质信号通路的扰动也不会破坏这种调节作用。M2毒蕈碱受体的激活可阻断D2调节,提示存在共享的信号元件。然而,蛋白激酶C的激活可减弱M2调节,而对D2调节无明显影响。综上所述,我们的结果表明,胆碱能中间神经元中D2多巴胺受体的激活通过膜限定的Gi/o类G蛋白途径降低N型Ca2+电流,该途径不受蛋白激酶C调节。这种信号通路可能是D2受体降低纹状体乙酰胆碱释放能力的基础。